Idiosyncratic adversity reported after oral consumption of an ayurvedic formulation containing bhallataka (Semecarpus anacardium): A case report
Open Access
- 30 November 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ayurveda and Integrative Medicine
- Vol. 13 (4), 100635
- https://doi.org/10.1016/j.jaim.2022.100635
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.2013
- Idiosyncratic Adverse Drug Reactions: Current ConceptsPharmacological Reviews, 2013
- Comparative study of amrutbhallataka and glucosamine sulphate in osteoarthritis: Six months open label randomized controlled clinical trialJournal of Ayurveda and Integrative Medicine, 2013
- Semecarpus anacardium Linn.: A reviewPharmacognosy Reviews, 2010
- HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinolProceedings of the National Academy of Sciences of the United States of America, 2005
- A marker for Stevens–Johnson syndromeNature, 2004
- Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 1998
- Studies on the mechanism of action of Semecarpus anacardium in rheumatoid arthritisJournal of Ethnopharmacology, 1989
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- HLA-B27, antinuclear antibodies and drug-induced agranulocytosisJournal of Molecular Medicine, 1978